February 14, 2020
On February 14, 2020, Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center hosted the monthly health policy consortium on sugar-sweetened beverage excise taxes.
In recent years, some cities have tried to impose soda taxes and other new policies to reduce the obesity epidemic in the US—particularly among children—and its critical impact on society and the health care system. How effective are these policies? What is blocking their uptake? What alternatives should we consider?
For more information visit our website at: https://petrieflom.law.harvard.edu/events/details/soda-taxes-and-other-policy-responses-to-the-american-obesity-epidemic
http://www.theheart.org/web_slides/1135309.do
A study on Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients (ADVANCE)
Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...InsideScientific
In this webinar, Dr. Michael Sturek reviews features of macrovascular atherosclerosis and microvascular dysfunction that underlie ischemic events and the need for appropriate animal models for optimal translation.
The unabated increase in cardiometabolic disease is a main reason why coronary heart disease remains the leading cause of death worldwide. Despite the effectiveness of lipid lowering therapy in treatment of coronary atherosclerosis, calcification remains a challenging clinical problem.
Lipid lowering therapy is highly effective in treating atherosclerosis, but statins and exercise have been shown to increase coronary artery calcification. Dr. Sturek will review data showing a predominance of intracellular calcium (Ca2+) release in coronary smooth muscle cells that decreases remarkably in cells from metabolic syndrome swine and humans. The early event in coronary artery calcification, i.e. the extracellular deposit of Ca2+ crystals as hydroxyapatite, may be triggered by impaired lysosomal Ca2+ signaling. Selective, novel modulation of lysosomal Ca2+ stores may alter autophagy and matrix vesicle release to treat coronary atherosclerosis and calcification.
Bahan Diskusi untuk Materi “Digital Leadership” PKN 1 Angkatan 52 Tahun 2022 dengan Tema “Presidensi G20 dan Peran Indonesia Dalam Menciptakan Tata Dunia Baru yang Lebih Berkeadilan”
Jakarta, 23 Februari 2022
http://www.theheart.org/web_slides/1135309.do
A study on Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients (ADVANCE)
Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...InsideScientific
In this webinar, Dr. Michael Sturek reviews features of macrovascular atherosclerosis and microvascular dysfunction that underlie ischemic events and the need for appropriate animal models for optimal translation.
The unabated increase in cardiometabolic disease is a main reason why coronary heart disease remains the leading cause of death worldwide. Despite the effectiveness of lipid lowering therapy in treatment of coronary atherosclerosis, calcification remains a challenging clinical problem.
Lipid lowering therapy is highly effective in treating atherosclerosis, but statins and exercise have been shown to increase coronary artery calcification. Dr. Sturek will review data showing a predominance of intracellular calcium (Ca2+) release in coronary smooth muscle cells that decreases remarkably in cells from metabolic syndrome swine and humans. The early event in coronary artery calcification, i.e. the extracellular deposit of Ca2+ crystals as hydroxyapatite, may be triggered by impaired lysosomal Ca2+ signaling. Selective, novel modulation of lysosomal Ca2+ stores may alter autophagy and matrix vesicle release to treat coronary atherosclerosis and calcification.
Bahan Diskusi untuk Materi “Digital Leadership” PKN 1 Angkatan 52 Tahun 2022 dengan Tema “Presidensi G20 dan Peran Indonesia Dalam Menciptakan Tata Dunia Baru yang Lebih Berkeadilan”
Jakarta, 23 Februari 2022
Scotland's Curriculum for Excellence: Into the futureEduSkills OECD
Scotland (United Kingdom) pioneered the approach to 21st-century curricula when it first conceived its Curriculum for Excellence (CfE). Rolled out in schools since 2010, CfE aims to provide students with a holistic, coherent, and future-oriented approach to learning between the ages of 3 and 18. In 2020, Scotland invited the OECD to assess the implementation of CfE in primary and secondary schools in order to understand the design and development of school curricula since 2015, aiming to uncover valuable lessons for other education systems and their own curriculum policies.
Disampaikan pada FGD Penyusunan Kerangka Indikator Riset dan Inovasi Daerah, Badan Riset dan Inovasi Nasional
JAKARTA, 16 MARET 2022
Dr. Tri Widodo W. Utomo, MA.
Deputi Kajian Kebijakan dan Inovasi Administrasi Negara LAN-RI
What is carbon pricing? What is carbon tax? Is carbon tax suitable for Indonesia condition? Can we implement carbon tax in Indonesia? What are the challenges of carbon tax implementation in Indonesia?
Paparan menteri ppn/kepala bappenas - sosialisasi visi indonesia 2045Ridho Fitrah Hyzkia
Sosialisasi Pemaparan Visi Indonesia 2045
oleh Menteri PPN/ Kepala Bappenas Prof. Bambang P.S. Brodjonegoro. Selasa, 8 Januari 2019
Ballroom - Hotel Fairmont Jakarta
Although stress hyperglycemia typically resolves as the acute illness or surgical stress abates, it is important to identify and track patients because 60% of patients admitted with new hyperglycemia had confirmed diabetes at 1 year. Furthermore stress induced by acute illness definitely impair metabolic control in known diabetic patients. Insulin is the therapy of choice in acutely ill hospitalised patients. You have to respect some important rules and algorithms, such as the Yale protocol, approaching insulin therapy in these patients, expecially to avoid the rollercoaster glycemic profile which subtends dangerous hypoglycemias and the increased risk of mortality. Use basal-bolus insulin regimens or continuous subcutaneous insulin infusion and tailor insulin regimens to the individual’s treatment.
New rapid-acting and long-acting insulin analogues profiles help to reach better glycemic control.
Scotland's Curriculum for Excellence: Into the futureEduSkills OECD
Scotland (United Kingdom) pioneered the approach to 21st-century curricula when it first conceived its Curriculum for Excellence (CfE). Rolled out in schools since 2010, CfE aims to provide students with a holistic, coherent, and future-oriented approach to learning between the ages of 3 and 18. In 2020, Scotland invited the OECD to assess the implementation of CfE in primary and secondary schools in order to understand the design and development of school curricula since 2015, aiming to uncover valuable lessons for other education systems and their own curriculum policies.
Disampaikan pada FGD Penyusunan Kerangka Indikator Riset dan Inovasi Daerah, Badan Riset dan Inovasi Nasional
JAKARTA, 16 MARET 2022
Dr. Tri Widodo W. Utomo, MA.
Deputi Kajian Kebijakan dan Inovasi Administrasi Negara LAN-RI
What is carbon pricing? What is carbon tax? Is carbon tax suitable for Indonesia condition? Can we implement carbon tax in Indonesia? What are the challenges of carbon tax implementation in Indonesia?
Paparan menteri ppn/kepala bappenas - sosialisasi visi indonesia 2045Ridho Fitrah Hyzkia
Sosialisasi Pemaparan Visi Indonesia 2045
oleh Menteri PPN/ Kepala Bappenas Prof. Bambang P.S. Brodjonegoro. Selasa, 8 Januari 2019
Ballroom - Hotel Fairmont Jakarta
Although stress hyperglycemia typically resolves as the acute illness or surgical stress abates, it is important to identify and track patients because 60% of patients admitted with new hyperglycemia had confirmed diabetes at 1 year. Furthermore stress induced by acute illness definitely impair metabolic control in known diabetic patients. Insulin is the therapy of choice in acutely ill hospitalised patients. You have to respect some important rules and algorithms, such as the Yale protocol, approaching insulin therapy in these patients, expecially to avoid the rollercoaster glycemic profile which subtends dangerous hypoglycemias and the increased risk of mortality. Use basal-bolus insulin regimens or continuous subcutaneous insulin infusion and tailor insulin regimens to the individual’s treatment.
New rapid-acting and long-acting insulin analogues profiles help to reach better glycemic control.
What is the Evidence and Return on Investment (ROI) of Obesity Prevention and...ICF
Originally presented at George Washington University's and ICF International's Research and Evaluation Forum (#GWICF2015), Dr. Ron Goetzel demonstrates why employers should look at value on investment (VOI) rather than return on investment (ROI) of workplace health promotion. Dr. Goetzel goes through:
• The severity and cost of obesity
• Why the workplace is the optimal environment for health programs
• Evidence and examples of how workplace health programs can bring VOI
• How employers can get VOI
To watch the video of Dr. Goetzel presenting these slides at the GW/ICF Research and Evaluation Forum, visit: http://www.icfi.com/ObesityPreventionRonGoetzel
Presentation by Commissioner Choucair at Northwestern University Feinberg School of Medicine Physician Assistant Program for a Public Health Presentation in Behavioral and Preventive Medicine I Course.
Obesity in America
Introduction
Definition of obesity
Causes of obesity
Statistics of Obesity in America.
Obesity is a condition where an individual have excess body fats leading to health problems. Obesity is an increasing problem in America with the rise in cases causing an alarm for the need to reduce the problem and promote healthy living. Statistics data released by health facilities and health institutions show an increasing trend of obesity in America. Obesity is caused by the uptake of high calorie food, genetic factors, lack of exercise and presence of underlying medical conditions.
2
Effects of Obesity
Low Quality Life
Increased medical expenses
Health problems
High Blood Pressure
Type ii Diabetes
Coronary heart Disease
Stroke
Hyperlidimia
Obesity has is associated with increased medical costs due to the health problems posed by the condition. Health problems associated with obesity are high blood pressure due to the high fat content deposited in the blood vessel lining. It also causes coronary heart disease, diabetes, stroke among many others. The condition also contributes to low quality life with high chances of causing death.
3
Inherency
Cause
Results from body storing excess energy in form of stored fats, thus by reducing intake can be a control measure.
Regulation of food intake as researched by professional cannot sustain control of increases in cases of obesity in society today. several factors interactions contribute to the situation. the causes have to first be understood. While most of the obesity cases are caused by excess consumption of food by an individual, it is also clear that some conditions are caused by more than excess consumption. This may include genetic, or other body disorders. The prevalence of the problem is increasing instead of reducing. Obesity rates have increased across all the population groups in the United States. It is therefore important to approach the problem from a different perspective.
Challenges being experienced can be grouped into the following major levels.
Intrapersonal Level
Interpersonal Level
Community/Institution Level
Macro/Public Policy Level
Medics and nutritionists have viewed the problem continuously as it could be solved through reducing the amount of food intake. However, body’s regulation of food consumption is not enough to deal with the epidemic. It is not a matter of the obese people decision to eat less food than they have been doing. It has been seen that obesity can be reduced through a different treatment of the problem. This may involve first deciding the root cause that triggers a person to eat so much food.
consumption is not enough to deal with the epidemic. It is not a matter of the obese people decision to eat less food than they have been doing. It has been seen that obesity can be reduced through a different treatment of the problem. This may involve first deciding the root cause that triggers a person to eat so much food. In.
Running head PICOT STATEMENT 1PICOT STATEMENT 5.docxtoltonkendal
Running head: PICOT STATEMENT 1
PICOT STATEMENT 5
PICOT Statement: Childhood Obesity
P-I-C-O-T Statement
P- Patients who suffer from obesity (BMI of more than 30)
I- Undertaking nutritional education, diet, and exercise
C- Comparison to nutritional education, endoscopic bariatric surgical intervention
O- Improved health outcomes in terms of overall weight
T - A year’s time limit
PICOT Statement: Childhood Obesity
Introduction
Childhood obesity poses serious health problems in the US as the number of overweight and obese population increases at a rapid pace every year. The effects of this problem have arrested the attention of policymakers, societal members, and government agencies. This has resulted in ranking childhood obesity as a national health concern. The adverse impacts of this disease go beyond the health realms to include economic burden on both personal and national budgets. While there are numerous risk factors and various evidence-based interventions to address this challenge, no single approach is consistently efficacious in curbing the disease. Consequently, it is imperative that efficacious initiatives and policies be developed to address the never-ending problem of childhood obesity. Multidisciplinary approaches are often broad and cut across all dimensions of personal health problems. Instead of placing emphasis solely on biomedical models, health care professionals should also seek to promote behavior change among obesity patients and their family members. A PICOT statement can be utilized as an effective tool to seek interventions of addressing childhood obesity.
PICOT Statement
Population
In the US, obesity prevalence is highest among children aged from 6 to 11 years (Cheung et al. 2016). The disease has tripled among this age group from 4.2 percent to 15.3 percent from 1963 to 2012. In the last three decades, increased cases of obesity prevalence have been noted among children of all ages, although the differences in obesity prevalence have been recorded in terms of age, race, ethnicity, and gender (Cheung et al. 2016). In this respect, children from socioeconomically disadvantaged families and some racial and ethnic minorities experience the higher median score on obesity than the dominant white population. Higher obesity rates are often recorded among blacks and Hispanics compared to whites. For instance, a survey on girls in the Southwest revealed that the yearly cases of obesity stood at 4.5 percent among Blacks, 2 percent among Hispanics, and 0.7 percent among white girls aged from 13 to 17 years (Cheung et al. 2016). For low-income earners, American Indians rank highest at 6.3 percent, followed closely by Hispanics at 5.5 percent.
Intervention
Evidence-based interventions that seek to reduce childhood obesity incidences in the country should target two major areas: prevention and treatment. High-quality RCT has been proven as one of the most effective preventative ...
American Heart Association Lifestyle Recommendations to Redu.docxSusanaFurman449
American Heart Association Lifestyle Recommendations to Reduce Obesity
Yuritza Medina
Chamberlain College of Nursing
NR709 Project and Practicum IV
Summer 2022
Abstract Past tense
The prevalence of obesity and sedentary lifestyle complications are increasing at alarming rates, representing a common but preventable cause of severe medical complications like diabetes, cardiovascular diseases, and early mortality. This common but chronic condition has been for a long time a public health concern and social determinant. The integrative review focused on how the American Heart Association (AHA) Diet and Lifestyle recommendations and the Fitbit app are used as innovative solutions to reduce obesity in adult patients. The Fitbit app offers a unique opportunity to enhance the efficacy of weight loss plans, as it is used to track activity, monitor steps, heart rate, energy expenditure, sleep, and sedentary behavior.
Research Methodology: A systematic review was conducted to identify research articles completed in the preceding 4-5 years centered on obesity care, diet, physical activity, activity trackers, and lifestyle implications. The databases searched were Chamberlain Library, PubMed, and CINHAL.
Results and Discussion: Initial searches yielded over 2000 articles, of which 45 were chosen and examined because they fit the integrative review's theme. The 15 papers most relevant to the PICOT question were studied in further detail and appraised using the Johns Hopkins Evidence Appraisal table. The studies reported positive physical activity outcomes. What were the key themes?
Conclusions and Further Recommendations:This systematic review supported the effectiveness of the AHA Diet and Lifestyle recommendations to prevent and reduce obesity, and clinical use is recommended. Fitbit app provides new ways to improve physical activity habits, and the easy availability of electronic devices may enhance their generalizability use.
Keywords: Obesity care; Obesity complications; Lifestyle recommendations; Obesity management; Physical activity intervention using Fitbit activity trackers.
Dedication
In dedication to my family for their steadfast support of this project; their cooperation means a lot to me. To my husband Armando, thank you for your love, understanding, and patience during this time. I credit my achievement to all of you for your unwavering love and belief in me.
Acknowledgments
First, I must acknowledge the help of all my professors from Chamberlain University, who inspired, encouraged, and supported me throughout the DNP program. My heartfelt thanks to my teammates, without whom I would never have completed this phase in my life. Their encouragement has had a significant influence on my strong determination during this trip.
Contents
American Heart Association Lifestyle Recommendations to Reduce Obesity 1
Abstract 2
Dedication 3
Acknowledgments 4
Introductio.
Childhood obesity, a very complex health issue that becomes a growing problem in the U.S. In fact, “over the past three decades, childhood obesity rates have tripled in the U.S., and today, the country has some of the highest obesity rates in the world: one out of six children is obese, and one out of three children is overweight or obese.” (Child obesity, n.d.). Physical diseases and conditions are often accompanying obesity. Also, obesity may have an adverse effect on various systems in a child’s body, such as heart, lungs, muscles and bones, kidneys, digestive tract, and hormones that control blood sugar and puberty. Furthermore, it can take a toll on social life because obese kids and teenagers are more likely to have low self-esteem. “Childhood obesity is one of the most serious threats to the health of our nation.” (Building evidence to prevent childhood obesity, n.d.). Children and youth who are obese and overweight will likely remain overweight or obese into adulthood.
References
Building evidence to prevent childhood obesity. (n.d.). Retrieved from https://www.rwjf.org/content/rwjf/en/how-we-work/grants-explorer/featured-programs/healthy-eating-research.html
Childhood obesity. (n.d.). Retrieved from https://www.hsph.harvard.edu/obesity-prevention-source/obesity-trends/global-obesity-trends-in-children/
1Running head OBESITY 4Running head OBESITY.docxvickeryr87
1
Running head: OBESITY
4
Running head: OBESITY
Obesity
NR503 Population Health, Epidemiology, & Statistical Principles
January 2018
Obesity
Obesity is a chronic medical condition and a significant health concern in the United States that is increasing worldwide. More than one third of the adults in the U.S. are obese. It is a leading cause of preventable illness and death (Centers for Disease Control and Prevention [CDC], 2016). This global epidemic is a leading concern for adults and for children who are predisposed to becoming obese as adults. This paper will discuss the significance of obesity in Florida, provide a background of the disease, review current surveillance and reporting methods, conduct a descriptive epidemiological analysis, discuss diagnosis and screening for prevention tools, develop an evidence based plan along with measureable outcomes to address obesity as an advanced practice nurse, and conclude with an overview of the main points presented.
Background and Significance
According to the CDC (2016), obesity is defined as “weight that is higher than what is considered as a healthy weight for a given height.” It involves excessive weight gain and accumulation of fat. In order to determine obesity, Body Mass Index or BMI is used to indirectly calculate a person’s body fat and health risk based on weight in relation to height. A BMI of 25.0 or above is considered overweight and 30.0 or greater is considered obese. Athletes with a greater amount of muscle mass may have a higher BMI even though they do not have excess body fat. Waist circumference is also used as a tool to diagnose obesity.
There are many causes that contribute to obesity, including behavioral, genetic, hormonal, environmental, and social factors. Increase in caloric intake, unhealthy eating habits, decrease in physical activity, certain medications, age, lack of sleep, quitting smoking, pregnancy, and certain medical disorders can contribute to weight gain (Mayo Clinic, 2018). Driving cars has replaced walking and riding bikes, technology has replaced engaging in physical activity, and easy access to cheaper foods has replaced nutritional importance. Most people are aware when weight is gained. Obvious signs and symptoms are tighter clothes, excess fat, and increased weight on a scale. Being overweight or obese increases the risk for many health diseases. Obesity may cause low endurance, breathing issues, excessive sweating, and joint discomfort. It can also lead to diabetes, gastroesophageal reflux disease, coronary heart disease, hypertension, high cholesterol, stroke, depression, and even certain types of cancer such as bowel, breast, and prostate cancer (Mayo Clinic, 2018).
Below is a map that highlights the obesity prevalence across the U.S. in 2016 according to the CDC. There is no significant difference in overall prevalence between men and women. The prevalence of women with a BMI > 35 is 18.3% compared to 12.5% of men. The.
1
Running head: OBESITY
3
Running head: OBESITY
Obesity
Lauren Urquiza
Chamberlain University
NR503 Population Health, Epidemiology, & Statistical Principles
January 2018
Obesity
Obesity is a chronic medical condition and a significant health concern in the United States that is increasing worldwide. More than one third of the adults in the U.S. are obese. It is a leading cause of preventable illness and death (Centers for Disease Control and Prevention [CDC], 2016). This global epidemic is a leading concern for adults and for children who are predisposed to becoming obese as adults. This paper will discuss the significance of obesity in Florida, provide a background of the disease, review current surveillance and reporting methods, conduct a descriptive epidemiological analysis, discuss diagnosis and screening for prevention tools, develop an evidence based plan along with measureable outcomes to address obesity as an advanced practice nurse, and conclude with an overview of the main points presented.
Background and Significance
According to the CDC (2016), obesity is defined as “weight that is higher than what is considered as a healthy weight for a given height.” It involves excessive weight gain and accumulation of fat. In order to determine obesity, Body Mass Index or BMI is used to indirectly calculate a person’s body fat and health risk based on weight in relation to height. A BMI of 25.0 or above is considered overweight and 30.0 or greater is considered obese. Athletes with a greater amount of muscle mass may have a higher BMI even though they do not have excess body fat. Waist circumference is also used as a tool to diagnose obesity.
There are many causes that contribute to obesity, including behavioral, genetic, hormonal, environmental, and social factors. Increase in caloric intake, unhealthy eating habits, decrease in physical activity, certain medications, age, lack of sleep, quitting smoking, pregnancy, and certain medical disorders can contribute to weight gain (Mayo Clinic, 2018). Driving cars has replaced walking and riding bikes, technology has replaced engaging in physical activity, and easy access to cheaper foods has replaced nutritional importance. Most people are aware when weight is gained. Obvious signs and symptoms are tighter clothes, excess fat, and increased weight on a scale. Being overweight or obese increases the risk for many health diseases. Obesity may cause low endurance, breathing issues, excessive sweating, and joint discomfort. It can also lead to diabetes, gastroesophageal reflux disease, coronary heart disease, hypertension, high cholesterol, stroke, depression, and even certain types of cancer such as bowel, breast, and prostate cancer (Mayo Clinic, 2018).
Below is a map that highlights the obesity prevalence across the U.S. in 2016 according to the CDC. There is no significant difference in overall prevalence between men and women. The prevalence of women with a BMI > 35 ...
Personal protective equipment or PPE has been a major topic of discussion across the nation. The COVID-19 pandemic has exposed major shortages of PPE and health care workers are being asked take care of patients with what some would argue is inadequate protection. The guidelines set by the CDC have changed and recommendations have even gone so far as to approve bandannas as a means for respiratory protection. Some have argued that it is unethical for health care workers to not have adequate protection, while others think it's their duty, protected or not. Adding to this debate has been theft, hoarding and disparate distribution of these critical supplies. During this panel discussion moderator Carmel Shachar, Stephen P. Wood, Christine Mitchell and Dr. Michael Mina explored the ethics of PPE in the COVID-19 pandemic.
March 27, 2020
Each year in low- and middle-income countries thousands of people are detained in hospitals for non-payment of medical bills, despite the fact that such detention is a violation of national and international law. Hospital detention for nonpayment of bills disproportionately affects the most vulnerable people, including post-partum women.
In the US, medical debt manifests itself in other ways, including bankruptcy, litigation to garnish wages, and foregone care. In both contexts, these scandals are the result of failures of financing, priority-setting, and legal oversight.
Without addressing these systemic issues, a "human right to health care" will remain a hollow slogan, as will political promises to achieve universal health coverage.
This event will feature Robert Yates of Chatham House, which has conducted an in-depth investigation of the global phenomenon of hospital detentions. Additional panelists will address manifestations of predatory lending and surprise medical fees in the United States, the ethical imperatives of financing and priority setting for UHC in general, and the implications for thinking about health care as a human right.
For more information, visit our website at: https://petrieflom.law.harvard.edu/events/details/debt-dignity-and-health-care
March 24, 2020
This event will highlight the challenges and opportunities in harnessing artificial intelligence (AI) technologies to serve the needs of individuals with disabilities and dependencies. AI can improve the lives of people with disabilities, such as smart devices supporting people with physical disabilities or sight loss. On the other hand, AI outputs can also reflect discriminatory biases present in the underlying data used to develop the algorithms. While this “garbage in, garbage out” principle is well documented in respect to AI and gender or race, it is understudied in respect to disability or dependencies.
Interdisciplinary panels of legal scholars, ethicists, AI developers, medical and service providers, and advocates with disabilities/ dependencies will explore best practices and guidelines for stakeholders, guided by ethical principles, legal considerations, and the needs of people with disabilities/ dependencies. Participants will seek to articulate clear criteria for developers and medical providers looking to harness the potential of AI to serve individuals with disabilities/ dependencies, including those whose disabilities/ dependencies are the result of aging, injury, or disease, and the caregivers -- including both professionals and unpaid friends and families -- who support some of these individuals.
This webinar was free and open the public.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/artificial-intelligence-and-disability-dependency
March 24, 2020
This event will highlight the challenges and opportunities in harnessing artificial intelligence (AI) technologies to serve the needs of individuals with disabilities and dependencies. AI can improve the lives of people with disabilities, such as smart devices supporting people with physical disabilities or sight loss. On the other hand, AI outputs can also reflect discriminatory biases present in the underlying data used to develop the algorithms. While this “garbage in, garbage out” principle is well documented in respect to AI and gender or race, it is understudied in respect to disability or dependencies.
Interdisciplinary panels of legal scholars, ethicists, AI developers, medical and service providers, and advocates with disabilities/ dependencies will explore best practices and guidelines for stakeholders, guided by ethical principles, legal considerations, and the needs of people with disabilities/ dependencies. Participants will seek to articulate clear criteria for developers and medical providers looking to harness the potential of AI to serve individuals with disabilities/ dependencies, including those whose disabilities/ dependencies are the result of aging, injury, or disease, and the caregivers -- including both professionals and unpaid friends and families -- who support some of these individuals.
This webinar was free and open the public.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/artificial-intelligence-and-disability-dependency
February 14, 2020
On February 14, 2020, Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center hosted the monthly health policy consortium on sugar-sweetened beverage excise taxes.
In recent years, some cities have tried to impose soda taxes and other new policies to reduce the obesity epidemic in the US—particularly among children—and its critical impact on society and the health care system. How effective are these policies? What is blocking their uptake? What alternatives should we consider?
For more information visit our website at: https://petrieflom.law.harvard.edu/events/details/soda-taxes-and-other-policy-responses-to-the-american-obesity-epidemic
October 23, 2019
The future of neuroscience and law will be a computational future, as both fields are increasingly integrating artificial intelligence and machine learning. But what will this future look like? Can AI and digital technologies promote justice, diversity, and inclusion? Or will these technologies replicate, or even exacerbate, existing inequalities and biases? In this lunchtime event, leading experts in artificial intelligence, computational psychiatry, and the law discussed these questions as they explored how AI and digital technologies can advance social good through improved social, psychiatric, and legal interventions.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/computational-justice
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
September 10, 2019
Book Talk: Birth Rights and Wrongs: How Medicine and Technology are Remaking Reproduction and the Law
Millions of Americans rely on the likes of birth control, IVF, and genetic testing to make plans as intimate and far-reaching as any over a lifetime. This is no less than the medicine of miracles. It fills empty cradles, frees families from terrible disease, and empowers them to fashion their lives on their own terms. But accidents happen.
Pharmacists mix up pills. Lab techs misread tests. Obstetricians tell women their healthy fetuses would be stillborn. Political and economic forces conspire against regulation. And judges throw up their hands when professionals foist parenthood on people who didn't want it, or childlessness on those who did. Failed abortions, switched donors, and lost embryos may be first-world problems. But these aren't innocent lapses or harmless errors. They're wrongs in need of rights.
At this event, author Dov Fox and an expert panel discussed his book Birth Rights and Wrongs: How Medicine and Technology are Remaking Reproduction and the Law (Oxford University Press, 2019). Panelists explored the ways in which the book seeks to lift the curtain on reproductive negligence, give voice to the lives it upends, and vindicate the interests that advances in medicine and technology bring to full expression. They also examined the book's effort to force citizens and courts to rethink the reproductive controversies of our time, and to equip us to meet the new challenges -- from womb transplants to gene editing -- that lie just over the horizon.
Learn more: https://petrieflom.law.harvard.edu/events/details/book-talk-birth-rights-and-wrongs
September 10, 2019
Book Talk: Birth Rights and Wrongs: How Medicine and Technology are Remaking Reproduction and the Law
Millions of Americans rely on the likes of birth control, IVF, and genetic testing to make plans as intimate and far-reaching as any over a lifetime. This is no less than the medicine of miracles. It fills empty cradles, frees families from terrible disease, and empowers them to fashion their lives on their own terms. But accidents happen.
Pharmacists mix up pills. Lab techs misread tests. Obstetricians tell women their healthy fetuses would be stillborn. Political and economic forces conspire against regulation. And judges throw up their hands when professionals foist parenthood on people who didn't want it, or childlessness on those who did. Failed abortions, switched donors, and lost embryos may be first-world problems. But these aren't innocent lapses or harmless errors. They're wrongs in need of rights.
At this event, author Dov Fox and an expert panel discussed his book Birth Rights and Wrongs: How Medicine and Technology are Remaking Reproduction and the Law (Oxford University Press, 2019). Panelists explored the ways in which the book seeks to lift the curtain on reproductive negligence, give voice to the lives it upends, and vindicate the interests that advances in medicine and technology bring to full expression. They also examined the book's effort to force citizens and courts to rethink the reproductive controversies of our time, and to equip us to meet the new challenges -- from womb transplants to gene editing -- that lie just over the horizon.
Learn more: https://petrieflom.law.harvard.edu/events/details/book-talk-birth-rights-and-wrongs
May 17, 2019
Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing.
As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics.
Presentation: Vardit Ravitsky, Associate Professor, Bioethics Programs, Department of Social and Preventive Medicine, School of Public Health, University of Montreal; Director, Ethics and Health Branch, Center for Research on Ethics - Prenatal Genome Sequencing: Ethical and Regulatory Implications for Post-Birth Access to Information
Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference
May 17, 2019
Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing.
As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics.
Presentation: Liza Vertinsky, Associate Professor of Law, Emory University School of Law and Emory Global Health Institute Faculty Fellow (with Yaniv Heled) - Genetic Privacy and Public Figures
Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference
May 17, 2019
Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing.
As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics.
Presentation: Scott Schweikart, Senior Research Associate, Council on Ethical and Judicial Affairs, American Medical Association and Legal Editor, AMA Journal of Ethics - Human Gene Editing: An Ethical Analysis and Arguments for Regulatory Guidance at Both the National and Global Levels
Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference
May 17, 2019
Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing.
As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics.
Presentation: Emily Qian, Genetic Counselor, Veritas Genetics (with Magalie Leduc, Rebecca Hodges, Bryan Cosca, Ryan Durigan, Laurie McCright, Doug Flood, and Birgit Funke) - Physician-Mediated Elective Whole Genome Sequencing Tests: Impacts on Informed Consent
Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference
May 17, 2019
Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing.
As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics.
Presentation: Seema Mohapatra, Associate Professor of Law, Indiana University Robert H. McKinney School of Law - Abolishing the Myth of “Anonymous” Gamete Donation in the Age of Direct-to-Consumer Genetic Testing
Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference
More from The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics (20)
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Steven Gortmaker, Sugar Sweetened Beverage Taxes: Impact on Health, Health Care Costs, and Health Disparities
1. Sugar Sweetened Beverage
Excise Taxes: Impact on
Health, Health Care Costs,
and Health Disparities
Steven Gortmaker PhD
Harvard Law School
February 14, 2020
2. CHOICES PROJECT
This work was supported in part by grants from The JPB Foundation, the National Institutes of Health
(R01HL146625), the Robert Wood Johnson Foundation(#66284), the Donald and Sue Pritzker
Nutrition and Fitness Initiative and the Centers for Disease Control and Prevention (U48DP001946),
including the Nutrition and Obesity Policy, Research and Evaluation Network. This work is solely the
responsibility of the authors and does not represent official views of the CDC or other funders
3. The Challenge
o Obesity rates are at historically high levels ages 2-
19
o Racial/ethnic & economic disparities persist
Ward et al., N Engl J Med, 2017
Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, Long MW, Gortmaker SL, N Engl J Med, 2019
Flegal et al., JAMA, 2016
Ogden et al., JAMA, 2016
Research continues to show
that more and more people
have developed obesity in
the U.S.
o About half of the adult U.S.
population will have obesity and
about a quarter will have severe
obesity by 2030
4. Ward ZJ, Long MW, Resch SC, Giles CM, Cradock AL, Gortmaker SL. N Engl J Med, 2017.
Doing nothing to address childhood obesity is not
an option
5. Costs of adults with excess weight
Wang YC, Pamplin J, Long MW, Ward ZJ, Gortmaker SL, Andreyeva T. (2015) Severe Obesity in Adults Cost State Medicaid Programs Nearly
$8 Billion in 2013. Health Aff 34:1923-2931
Obesity health care costs are $116 billion per year
Severe obesity (BMI >35) accounts for $69 billion of this
6. What can we do about this?
o There is strong evidence linking intake sugar
sweetened beverages to excess weight gain
and future chronic disease
o Note that research supporting this work has
occurred just in the past two decades (Our
Lancet study in 2001 was the first longitudinal
study showing the link to obesity in youth)
o Added sugars are mainly found in SSBs in the
US. These are generally nutritionally poor
beverages – sugar and water and some
flavoring.
Malik VS, Pan A, Willett WC, Hu FB. Am J Clin Nutr. 2013 Oct;98(4):1084-102.
Ludwig DS, Peterson KE, Gortmaker SL. Lancet. 2001 Feb 17;357(9255):505-8.
7. Why Reduce Sugar Drink Intake?
U.S. Dietary Guidelines 2015-2020
Figure 2-9. Average Intakes
of Added Sugars as a
Percent of Calories per Day
by Age-Sex Group, in
Comparison to the Dietary
Guidelines Maximum Limit
of Less Than 10 Percent of
Calories
8. Why Reduce Sugar Drink Intake?
U.S. Dietary Guidelines 2015-2020
Figure 2-10. Food Category
Sources of Added Sugars in
the U.S. Population Ages 2
Years and Older
9. CHOICES- Why are we doing this?
Policies and
programs
improving
nutrition and
physical
activity
environments
Best results
for dollars
invested
We want to
improve
population
health via
public policies
and programs
Gortmaker SL, Claire Wang Y, Long MW, Giles CM, Ward ZJ, Barrett JL, Kenney EL, Sonneville KR, Afzal AS, Resch SC, Cradock AL.
Three Interventions That Reduce Childhood Obesity Are Projected to Save More Than They Cost to Implement. Health Affairs, 34, no.
11 (2015):1304-1311.
11. More Informed Decision-Making
o Cost-effectiveness framework provides an
opportunity across strategies and health
outcomes for better decision making
• Evidence for impact on health
• Population reach
• Implementation resources, activities &
costs
• Potential impact on disparities
15. Project impact on the
population
The CHOICES microsimulation model projects
the future course of the childhood obesity
epidemic by evaluating how an identified
strategy will impact obesity, healthcare costs
& mortality outcomes over 10 years
16. CHOICES model intervention inputs
Reach
Who will benefit?
Effect
What is effect of
the policy/program
on health?
Cost
Implementation
costs of
program/policy and
healthcare cost
savings
Focus on implementation of interventions to improve nutrition &
physical activity environments
Dietz WH, Gortmaker SL. New Strategies to Prioritize Nutrition, Physical Activity, and Obesity Interventions. Am J Prev Med.
2016 Apr 26. pii: S0749-3797(16)30069-1.
17. How does an SSB Excise Tax work?
o Most current SSB taxes are volume taxes – say
$0.01 per oz (Berkeley CA), or $0.02 per oz
(Boulder CO). ($0.0175 oz on Seattle)
o You can also tax the amount of sugar (e.g. UK).
o Note this is not a sales tax
o The tax raises the price, so people buy less and
then consume less, potentially leading to less
excess weight gain and reduced risk of future
chronic disease
o This approach worked well with tobacco
18. How the CHOICES Model Works
OUTCOMES
Simulate to:
2025
Healthcare
Costs
Mortality
Obesity
HEALTH
STATUS
BMI
INDIVIDUAL
Body Growth
Personal
Characteristics
(e.g. dietary intake)
Smoking
POPULATION
Population
Growth
BMI Trends
Start: 2015
VIRTUAL
POPULATION
From 2010 U.S.
Census Data
BASELINE SCENARIO
Obesity
QALYs
19. OUTCOMES
Simulate to:
2025
Healthcare
Costs
Mortality
Obesity
HEALTH
STATUS
Obesity
How the CHOICES Model Works
INTERVENTION SCENARIO
INTERVENTION
DietaryIntake/PhysicalActivity
INDIVIDUAL
FACTORS
Body Growth
Personal
Characteristics
(e.g. dietary intake)
Smoking
POPULATION
FACTORS
Population
Growth
BMI Trends
Start: 2015
VIRTUAL
POPULATION
From 2010 U.S.
Census Data
INTERVENTION SCENARIO
20. What has CHOICES been finding?
Some strategies are cost-saving
Many strategies reaching only children require
investment
Include adults for immediate large health care
cost savings
Strategies across sectors improve population
health
Some strategies projected to reduce disparities
22. 22
CHOICES Metrics: 3 examples
Metric Definition
Cases of Childhood Obesity
Prevented in 2025
How many cases of childhood obesity will be prevented
in the intervention model compared to no intervention
in 2025?
Net costs The cost of implementing the intervention minus the
health care cost savings; a negative number means
intervention is cost saving
Health Care Cost Saved per $1
Invested
For every $1 invested to implement the intervention,
how much money is saved in health care costs with the
reduction in obesity in the population?
23. NET COST SAVINGS AFTER 10 YEARS CASES OF CHILDHOOD
OBESITY PREVENTED IN 2025
NET COST AFTER 10 YEARS
Example: Interventions to reduce childhood obesity
1The SSB Tax intervention would also produce an estimated $12.5 (2015) billion/year in tax revenue. This is not included
in the cost-effectiveness analysis
2 95% uncertainty interval
576,000SSB Tax1
$-14.2 billion
($-2.65, $-47.1)2
(132,000, 1,890,000)2
Smart
Snacks
$-792 million 344,649
($-251, $-1,340)2
(163,000, 522,000)2
Bariatric
Surgery
$303 million No cases
($209, $401)2
24. No effect on cases
HEALTH CARE COST SAVINGS Per $1 INVESTED1
Bariatric
Surgery
1Gortmaker SL, Claire Wang Y, Long MW, Giles CM, Ward ZJ, Barrett JL, Kenney EL, Sonneville KR, Afzal AS, Resch SC,
Cradock AL. Three Interventions That Reduce Childhood Obesity Are Projected to Save More Than They Cost to
Implement. Health Affairs, 34, no. 11 (2015):1304-1311.
2 95% uncertainty intervals
Example: Interventions to reduce childhood obesity
$30.80
($6.10, $113)2
SSB Tax
$4.60
($2.10, $7)2
Smart
Snacks
25. Impact of SSB Excise Tax on Percentage Reduction (95% UI)
in Childhood Obesity Prevalence, by Race/Ethnicity
0.77%
1.04%
1.02%
0.00% 0.50% 1.00%
White
Black
Hispanic
1.32 times greater,
compared to White
Long MW, Ward ZJ, Barrett JL, Cradock AL, Resch SC, Wang, YC, Giles CM, Gortmaker, SL. Taxing Sugar-sweetened Beverages Estimated to
Reduce Racial/Ethnic Disparities in U.S. Obesity Prevalence. American Public Health Association, Denver CO, 2016.
1.35 times greater,
compared to White
26. 0.91%
0.87%
0.86%
0.80%
0.00% 0.20% 0.40% 0.60% 0.80% 1.00%
≤130% poverty level
131-185% poverty level
186-350% poverty level
>350% poverty level
1.14 times greater, compared
to highest income
1.09 times greater, compared
to highest income
Impact of SSB Excise Tax on Percentage Reduction (95% UI) in
Childhood Obesity Prevalence, by household income
1.07 times greater, compared
to highest income
Long MW, Ward ZJ, Barrett JL, Cradock AL, Resch SC, Wang, YC, Giles CM, Gortmaker, SL. Taxing Sugar-sweetened Beverages Estimated to
Reduce Racial/Ethnic Disparities in U.S. Obesity Prevalence. American Public Health Association, Denver CO, 2016.
27. Summary: Cost-Effectiveness of SSB Excise Tax
o A Sugar Sweetened Beverage excise tax ($0.01 per
ounce) is projected to prevent future obesity and save
more in health care costs than it cost to implement
o This strategy will also likely improve population health
equity while improving population health overall
o In addition, the tax would raise an additional $12.5
billion per year in revenue that could be used for other
preventive programs